Education
About Us
Working with TipRanks
Follow Us
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
1652 Stock Chart & Stats
HK$0.73
-HK$0.03(-4.41%)
At close: 4:00 PM EST
HK$0.73
-HK$0.03(-4.41%)
Day’s Range― - ―
52-Week RangeHK$0.24 - HK$1.75
Previous CloseN/A
Volume70.00K
Average Volume (3M)1.77M
Market Cap
HK$691.11M
Enterprise ValueHK$603.14M
Total Cash (Recent Filing)HK$21.06M
Total Debt (Recent Filing)HK$383.69M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Apr 07, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 07, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding739,301,000
10 Day Avg. Volume1,889,460
30 Day Avg. Volume1,765,153
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.50
Price to Sales (P/S)1.71
P/FCF Ratio9.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Fusen Pharmaceutical Co., Ltd. News
1652 FAQ
What was Fusen Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Fusen Pharmaceutical Co., Ltd. lowest stock price was HK$0.23 and its highest was HK$1.75 in the past 12 months.
What is Fusen Pharmaceutical Co., Ltd.’s market cap?
Fusen Pharmaceutical Co., Ltd.’s market cap is HK$691.11M.
When is Fusen Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Fusen Pharmaceutical Co., Ltd.’s upcoming earnings report date is Apr 07, 2026 which is in 155 days.
How were Fusen Pharmaceutical Co., Ltd.’s earnings last quarter?
Fusen Pharmaceutical Co., Ltd. released its earnings results on Aug 29, 2025. The company reported -HK$0.034 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.034.
Is Fusen Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Fusen Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Fusen Pharmaceutical Co., Ltd. pay dividends?
Fusen Pharmaceutical Co., Ltd. pays a Notavailable dividend of HK$0.004 which represents an annual dividend yield of N/A. See more information on Fusen Pharmaceutical Co., Ltd. dividends here
What is Fusen Pharmaceutical Co., Ltd.’s EPS estimate?
Fusen Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fusen Pharmaceutical Co., Ltd. have?
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding.
What happened to Fusen Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Fusen Pharmaceutical Co., Ltd. reported an EPS of -HK$0.034 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Fusen Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in HK:1652
Fusen Pharmaceutical Co., Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.05%
12-Months-Change
Fundamentals
Return on Equity
-40.38%
Trailing 12-Months
Asset Growth
-6.03%
Trailing 12-Months
Company Description
Fusen Pharmaceutical Co., Ltd.
Fusen Pharmaceutical Co., Ltd. (1652) is a leading pharmaceutical company based in Taiwan, specializing in the research, development, manufacturing, and marketing of innovative pharmaceutical products. The company primarily operates in the sectors of prescription drugs, over-the-counter medications, and health supplements. Fusen focuses on a diverse portfolio of therapeutic areas, including oncology, cardiology, and infectious diseases, contributing to improved healthcare outcomes.
Technical Analysis
Tianda Pharmaceuticals Ltd.
―
China NT Pharma Group Co., Ltd.
―
PuraPharm Corp. Ltd.
―
Zhongzhi Pharmaceutical Holdings Limited
―
Huakang Biomedical Holdings Company Limited
―